Division of Cardiology, Amagasaki Chuo Hospital, 1-12-1 Shioe, Amagasaki, Hyogo, 661-0976, Japan.
Department of Medical Informatics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871, Japan.
BMC Cardiovasc Disord. 2021 Jun 7;21(1):281. doi: 10.1186/s12872-021-02098-z.
Complicated pathophysiology makes it difficult to identify the prognosis of heart failure with preserved ejection fraction (HFpEF). While plasma osmolality has been reported to have prognostic importance, mainly in heart failure with reduced ejection fraction (HFrEF), its prognostic meaning for HFpEF has not been elucidated.
We prospectively studied 960 patients in PURSUIT-HFpEF, a multicenter observational study of acute decompensated HFpEF inpatients. We divided patients into three groups according to the quantile values of plasma osmolality on admission. During a follow-up averaging 366 days, we examined the primary composite endpoint of cardiac mortality or heart failure re-admission using Kaplan-Meier curve analysis and Cox proportional hazard testing.
216 (22.5%) patients reached the primary endpoint. Kaplan-Meier curve analysis revealed that the highest quantile of plasma osmolality on admission (higher than 300.3 mOsm/kg) was significantly associated with adverse outcomes (Log-rank P = 0.0095). Univariable analysis in the Cox proportional hazard model also revealed significantly higher rates of adverse outcomes in the higher plasma osmolality on admission (hazard ratio [HR] 7.29; 95% confidence interval [CI] 2.25-23.92, P = 0.0009). Multivariable analysis in the Cox proportional hazard model also showed that higher plasma osmolality on admission was significantly associated with adverse outcomes (HR 5.47; 95% CI 1.46-21.56, P = 0.0113) independently from other confounding factors such as age, gender, comorbid of atrial fibrillation, hypertension history, diabetes, anemia, malnutrition, E/e', and N-terminal pro-B-type natriuretic peptide elevation.
Higher plasma osmolality on admission was prognostically important for acute decompensated HFpEF inpatients.
复杂的病理生理学使得难以确定射血分数保留的心力衰竭(HFpEF)的预后。虽然已有研究报道血浆渗透压对预后具有重要意义,主要在射血分数降低的心力衰竭(HFrEF)中,但它对 HFpEF 的预后意义尚未阐明。
我们前瞻性地研究了 PURSUIT-HFpEF 中的 960 例患者,这是一项急性失代偿性 HFpEF 住院患者的多中心观察性研究。我们根据入院时血浆渗透压的分位数值将患者分为三组。在平均 366 天的随访期间,我们使用 Kaplan-Meier 曲线分析和 Cox 比例风险检验检查了主要复合终点,即心脏死亡或心力衰竭再入院。
216(22.5%)例患者达到了主要终点。Kaplan-Meier 曲线分析显示,入院时最高的血浆渗透压分位数(高于 300.3 mOsm/kg)与不良结局显著相关(Log-rank P=0.0095)。Cox 比例风险模型中的单变量分析也显示,入院时较高的血浆渗透压与不良结局发生率显著相关(危险比 [HR] 7.29;95%置信区间 [CI] 2.25-23.92,P=0.0009)。Cox 比例风险模型中的多变量分析也显示,入院时较高的血浆渗透压与不良结局显著相关(HR 5.47;95%CI 1.46-21.56,P=0.0113),独立于其他混杂因素,如年龄、性别、心房颤动合并症、高血压史、糖尿病、贫血、营养不良、E/e'和 N 末端 pro-B 型利钠肽升高。
入院时较高的血浆渗透压对急性失代偿性 HFpEF 住院患者的预后具有重要意义。